A

Amplyx Pharmaceuticals, Inc

7 employees

Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology

Medical

Pharmaceutical

Clinical Trials

Date founded

2006

Funding rounds raised

Total raised

$67M

from 15 investors over 15 rounds

A

Amplyx Pharmaceuticals, Inc raised $53M on May 19, 2020

Investors: Lundbeckfonden / Lundbeck Foundation, RiverVest Venture Partners, Adage Capital Management, Pappas Capital, Sofinnova Ventures, Russia technology fund and Arix Bioscience plc

A

Amplyx Pharmaceuticals, Inc raised $67M on August 1, 2017

Investors: RiverVest Venture Partners, Lundbeckfonden / Lundbeck Foundation, Arix Bioscience plc, Pappas Capital, Sofinnova Ventures, Russia technology fund and Generation Ventures

A

Amplyx Pharmaceuticals, Inc raised $41M on November 11, 2015

Investors: RiverVest Venture Partners

A

Amplyx Pharmaceuticals, Inc raised undisclosed on January 1, 2009

Investors: Keiretsu Forum / Capital

A

Amplyx Pharmaceuticals, Inc raised undisclosed on September 22, 2008

Investors: -